Læknablaðið

Árgangur

Læknablaðið - 15.10.1983, Blaðsíða 33

Læknablaðið - 15.10.1983, Blaðsíða 33
LÆKNABLADID 255 the more efficient repair of the lesion, may account for its lack of carcinogenicity. Based on the available data, no general correlation between chemically induced DNA damage and species differences in tumor induction can be made. That such a correlation may exist, however, is not inconsistent with the data presently available. C. Proliferative Status of Target Cells There may be a fundamental difference in the consequences of error accumulation between DNA of dividing and nondividing cells. In dividing cells, one is mainly concerned with replicative error propagation; that is, the transmission of mistakes in DNA replication from one generation to the next. Mechanisms which enhance the frequency of such mistakes could involve alterations in the DNA synthetic apparatus and have been referred to as intrinsic mutagenesis (4). In nondividing cells, one is mainly concerned with the accumula- tion of unrepaired DNA damage. In the mechanism of carcinogenesis, consideration is normally limited to either dividing cells or to resting cells destined to undergo at least one further division cycle. If damaged DNA is repaired by a faithful, »error-free« mecha- nism, the damage is probably inconsequfential with respect to cancer. Misrepair of DNA damage as a mechanism of cancer is possible since there is substantial evidence for the induction of an error-prone repair pathway (SOS) in bacteria and eukaryotes (15, 78). The underlying concept of this repair pathway is that it can alleviate potentially lethal damage, but only with a high probability of inducing mutations. The induction of this pathway could be a programmed expression of cancer or could be permanently induced by damage to DNA at a site that regulates this pathway. The importance of DNA replication in the development of tumors has been extensively studied. Replication is required for fixation of DNA damage and the progression of a dormant initiated cell to a clinically recog- nized tumor (20). Thus, the next stage in carcinogenesis (promotion) involved a loss of response to normal control of cell prolifera- tion (29, 30), and only a few rounds of DNA replication may be needed to amplify and stabilize errors introduced by chemical carci- nogens. Several compounds such as perchlo- roethylene, chloroform, or 1,4-dioxane, which are minimally genotoxic in most bacterial tests, induce tumors in mice while causing substantial necrosis in the target tissues. The mechanism underlying the tumor formation by these compounds is unclear. However, a hypothesis has been proposed postulating the restorative hyperplasia from the cytotoxicity of these compounds as the mechanism for tumor formation (69). This might occur by either growth stimulation of pre-existing transformed cells to the extent that they become independent of normal physiological growth inhibitors, or by increasing the chan- ces for errors during the DNA replication process. Manipulating the rate of cellular proliferation may thus modify the tumor incidence as has been shown with partial hepatectomy, methylnitrosourea, dimethylni- trosourea, benzo(a)pyrene, diet, drugs, natural physiological agents (hormones, bile acids) or the stimulated regenerative hyperplasia result- ing from the toxic effect of carbon tetrachlo- ride and 2-acetylaminofluorene (69). On the other hand, the stabilization of the differentiat- ed nondividing state of epithelial cells by retinoids has been used as a way of inhibiting mammary and colon carcinogenesis (42, 47). The degree of normal replication potential and the relative effect of various exogenous and endogenous agents on the rate of this process may, to a large extent, determine the susceptibility to chemical carcinogens. III. PROMOTION A. Effects of Promoters Tumor promotion is experimentally defined as the appearance of tumors induced by sequen- tial treatment of animals with an initiator (such as an incomplete carcinogen or a low dose of a complete carcinogen) followed by long-term application of a promoter. Under the same experimental conditions, neither initiator nor promoter alone can induce tu- mors, nor can a regimen of promoter first followed by initiator. Thus, the requirement for synergistic effects between initiators and promoters in order to induce tumor formation is a critical feature of the initiation-promotion systems. A long interval between application of initiator and promoter will still produce tu- mors since initiators induce a stable or perma-
Blaðsíða 1
Blaðsíða 2
Blaðsíða 3
Blaðsíða 4
Blaðsíða 5
Blaðsíða 6
Blaðsíða 7
Blaðsíða 8
Blaðsíða 9
Blaðsíða 10
Blaðsíða 11
Blaðsíða 12
Blaðsíða 13
Blaðsíða 14
Blaðsíða 15
Blaðsíða 16
Blaðsíða 17
Blaðsíða 18
Blaðsíða 19
Blaðsíða 20
Blaðsíða 21
Blaðsíða 22
Blaðsíða 23
Blaðsíða 24
Blaðsíða 25
Blaðsíða 26
Blaðsíða 27
Blaðsíða 28
Blaðsíða 29
Blaðsíða 30
Blaðsíða 31
Blaðsíða 32
Blaðsíða 33
Blaðsíða 34
Blaðsíða 35
Blaðsíða 36
Blaðsíða 37
Blaðsíða 38
Blaðsíða 39
Blaðsíða 40
Blaðsíða 41
Blaðsíða 42
Blaðsíða 43
Blaðsíða 44
Blaðsíða 45
Blaðsíða 46
Blaðsíða 47
Blaðsíða 48
Blaðsíða 49
Blaðsíða 50
Blaðsíða 51
Blaðsíða 52
Blaðsíða 53
Blaðsíða 54
Blaðsíða 55
Blaðsíða 56
Blaðsíða 57
Blaðsíða 58
Blaðsíða 59
Blaðsíða 60
Blaðsíða 61
Blaðsíða 62
Blaðsíða 63
Blaðsíða 64

x

Læknablaðið

Beinir tenglar

Ef þú vilt tengja á þennan titil, vinsamlegast notaðu þessa tengla:

Tengja á þennan titil: Læknablaðið
https://timarit.is/publication/986

Tengja á þetta tölublað:

Tengja á þessa síðu:

Tengja á þessa grein:

Vinsamlegast ekki tengja beint á myndir eða PDF skjöl á Tímarit.is þar sem slíkar slóðir geta breyst án fyrirvara. Notið slóðirnar hér fyrir ofan til að tengja á vefinn.